1. [Cardiogenic shock is a rare disease: the dedicated network].
- Author
-
Valente S, Marini M, Battistoni I, Sorini Dini C, Di Mario C, De Maria R, Aspromonte N, Cacciavillani L, Ferraiuolo G, Iacoviello M, Casolo G, Di Lenarda A, and Gulizia MM
- Subjects
- Checklist, Decision Trees, Humans, Referral and Consultation, Rare Diseases diagnosis, Rare Diseases therapy, Shock, Cardiogenic diagnosis, Shock, Cardiogenic therapy
- Abstract
Cardiogenic shock (CS) is a rare disease that needs a rapid and multiparameter diagnosis and a timely, aggressive and multidisciplinary goal-oriented treatment. Recently published epidemiological studies and registries underline how SC represents an infrequent clinical entity still burdened by high mortality rates, substantially unchanged over the years. Currently, only few patients with CS are treated with circulatory assistance in dedicated centers. Some consensus documents and expert recommendations emphasize the importance of early diagnosis of CS, immediate pharmacological support, and treatment of precipitating causes, and stress the need for hospitalization in high-volume intensive care centers. The aim of this review is to show the instructions for the creation of a SC network, emphasizing the necessary elements, in agreement with available resources and existing health regulations for giving the same care opportunities to all the patients.
- Published
- 2017
- Full Text
- View/download PDF